Prevalence of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitor Prescribing in Patients with Type 2 Diabetes Mellitus and Reduced Estimated Glomerular Filtration Rate

• Main Authors: Kayla Chonko (Author), Giavanna Russo-Alvarez (Author), Diana Isaacs (Author), Lu Wang (Author), Amanda Soric (Author)
• Format: Book
• Published: University of Minnesota Libraries Publishing, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Sodium glucose cotransporter 2 (SGLT-2) inhibitors have demonstrated benefit in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), including slowing the progression of CKD and lowering the risk of kidney failure and death. Despite this evidence, literature suggests SGLT-2...